"After screening the effective antigen, we will continue to investigate the cocktail vaccine for the screen of a better protective effect. To further verify the persistence and safety of the recombinant antigen with Quil A, the long-lasting antibody-level experiment of the vaccine and allergy study on guinea pigs will be conducted."